Improved Delineation of Cardiac Pathology Using a Novel Three-Dimensional Echocardiographic Tissue Transparency Tool.


Journal

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
ISSN: 1097-6795
Titre abrégé: J Am Soc Echocardiogr
Pays: United States
ID NLM: 8801388

Informations de publication

Date de publication:
11 2020
Historique:
received: 08 07 2020
revised: 01 08 2020
accepted: 03 08 2020
pubmed: 26 9 2020
medline: 21 9 2021
entrez: 25 9 2020
Statut: ppublish

Résumé

Accurate visualization of cardiac valves and lesions by three-dimensional (3D) echocardiography is integral for optimal guidance of structural procedures and appropriate selection of closure devices. A new 3D rendering tool known as transillumination (TI), which integrates a virtual light source into the data set, was recently reported to effectively enhance depth perception and orifice definition. We hypothesized that adding the ability to adjust transparency to this tool would result in improved visualization and delineation of anatomy and pathology and improved localization of regurgitant jets compared with TI without transparency and standard 3D rendering. We prospectively studied 30 patients with a spectrum of structural heart disease who underwent 3D transesophageal imaging (EPIQ system, Philips) with standard acquisition and TI with and without the transparency feature. Six experienced cardiologists and sonographers were shown randomized images of all three display types in a blinded fashion. Each image was scored independently by all experts using a Likert scale from 1 to 5, while assessing each of the following aspects: (1) ability to recognize anatomy, (2) ability to identify pathology, including regurgitant jet origin, (3) depth perception, and (4) quality of border delineation. TI images with transparency were successfully obtained in all cases. All experts perceived an incremental value of the transparency mode, compared with TI without transparency and standard 3D rendering, in terms of ability to recognize anatomy (respective scores: 4.5 ± 1.1 vs 4.1 ± 1.1 vs 3.6 ± 1.1, P < .05), ability to identify pathology (4.1 ± 1.1 vs 3.9 ± 1.2 vs 3.3 ± 1, P < .05), depth perception (4.6 ± 0.7 vs 4.1 ± 0.8 vs 3.2 ± 1.0, P < .05), and border delineation (4.6 ± 0.8 vs 4.1 ± 1.0 vs 3.1 ± 1.1, P < .05). The addition of the transparency mode to TI rendering significantly improves the diagnostic and clinical utility of 3D echocardiography and has the potential to markedly enhance echocardiographic guidance of cardiac structural interventions.

Sections du résumé

BACKGROUND
Accurate visualization of cardiac valves and lesions by three-dimensional (3D) echocardiography is integral for optimal guidance of structural procedures and appropriate selection of closure devices. A new 3D rendering tool known as transillumination (TI), which integrates a virtual light source into the data set, was recently reported to effectively enhance depth perception and orifice definition. We hypothesized that adding the ability to adjust transparency to this tool would result in improved visualization and delineation of anatomy and pathology and improved localization of regurgitant jets compared with TI without transparency and standard 3D rendering.
METHODS
We prospectively studied 30 patients with a spectrum of structural heart disease who underwent 3D transesophageal imaging (EPIQ system, Philips) with standard acquisition and TI with and without the transparency feature. Six experienced cardiologists and sonographers were shown randomized images of all three display types in a blinded fashion. Each image was scored independently by all experts using a Likert scale from 1 to 5, while assessing each of the following aspects: (1) ability to recognize anatomy, (2) ability to identify pathology, including regurgitant jet origin, (3) depth perception, and (4) quality of border delineation.
RESULTS
TI images with transparency were successfully obtained in all cases. All experts perceived an incremental value of the transparency mode, compared with TI without transparency and standard 3D rendering, in terms of ability to recognize anatomy (respective scores: 4.5 ± 1.1 vs 4.1 ± 1.1 vs 3.6 ± 1.1, P < .05), ability to identify pathology (4.1 ± 1.1 vs 3.9 ± 1.2 vs 3.3 ± 1, P < .05), depth perception (4.6 ± 0.7 vs 4.1 ± 0.8 vs 3.2 ± 1.0, P < .05), and border delineation (4.6 ± 0.8 vs 4.1 ± 1.0 vs 3.1 ± 1.1, P < .05).
CONCLUSIONS
The addition of the transparency mode to TI rendering significantly improves the diagnostic and clinical utility of 3D echocardiography and has the potential to markedly enhance echocardiographic guidance of cardiac structural interventions.

Identifiants

pubmed: 32972777
pii: S0894-7317(20)30517-4
doi: 10.1016/j.echo.2020.08.005
pmc: PMC7920620
mid: NIHMS1671363
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1316-1323

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007381
Pays : United States

Informations de copyright

Copyright © 2020 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Références

Biomed Res Int. 2015;2015:547364
pubmed: 26665006
Heart Rhythm. 2016 Jul;13(7):1402-9
pubmed: 27016474
JACC Cardiovasc Imaging. 2019 Sep;12(9):1868-1871
pubmed: 30772235

Auteurs

Ilya Karagodin (I)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Karima Addetia (K)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Amita Singh (A)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Alasdair Dow (A)

Philips Medical Systems, Amsterdam, Netherlands.

Lydia Rivera (L)

Philips Medical Systems, Amsterdam, Netherlands.

Jeanne M DeCara (JM)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Laurie Soulat-Dufour (L)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois; Sorbonne University, APHP, Paris, France.

Megan Yamat (M)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Eric Kruse (E)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Atman P Shah (AP)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Victor Mor-Avi (V)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Roberto M Lang (RM)

Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois. Electronic address: rlang@medicine.bsd.uchicago.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH